Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Phase 4
Completed
- Conditions
- Alzheimer's Disease
- Registration Number
- NCT00165724
- Lead Sponsor
- Eisai Korea Inc.
- Brief Summary
Open study for efficacy and safety of donepezil treatment during 48 weeks
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method ADAS-cog
- Secondary Outcome Measures
Name Time Method MMSE, CDR, GDS, NPI, ADL, SSDQ
Trial Locations
- Locations (7)
Yeungnam University Hospital
🇰🇷Daegu, Korea, Republic of
Changwon Fatima Hospital
🇰🇷Changwon, Korea, Republic of
Bobath Memorial Hospital
🇰🇷Bundang, Korea, Republic of
Bundang Seoul National University Hospital
🇰🇷Bundang, Korea, Republic of
Catholic University Hospital
🇰🇷Seoul, Korea, Republic of
Inha University Hospital
🇰🇷Incheon, Korea, Republic of
Eulji University Hospital
🇰🇷Seoul, Korea, Republic of